NCT02699866

Brief Summary

The Straumann Bone Level Tapered (BLT) implant Ø 2.9 mm implant was developed to allow treatment of patients with single tooth gaps of small dimensions in the lateral and central incisor positions in the mandible and in the lateral incisor positions in the maxilla. These positions are reduced-load-bearing compared to more posterior positions. During this study performance and safety of the Straumann BLT implants Ø 2.9 mm in the clinical practice setting will be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

March 1, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2016

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
10 months until next milestone

Results Posted

Study results publicly available

September 17, 2020

Completed
Last Updated

August 31, 2021

Status Verified

August 1, 2021

Enrollment Period

3.4 years

First QC Date

March 1, 2016

Results QC Date

August 25, 2020

Last Update Submit

August 5, 2021

Conditions

Keywords

Small diameter implant

Outcome Measures

Primary Outcomes (1)

  • Implant Survival Rate at 12 Months After Implant Placement

    A "surviving implant" is an implant stably inserted in the subject's jaw bone at the time of assessment.

    12 months after implant placement

Secondary Outcomes (1)

  • Pink Esthetic Score (PES) at 6 Months After Implant Placement

    6 months after implant placement

Other Outcomes (3)

  • Implant Success Rate at 12 Months After Implant Placement

    12 months after implant placement

  • Marginal Bone Level Changes at 12 Months After Implant Placement

    Baseline and 12 months after implant placement

  • Incidence of Adverse Events and Adverse Device Effects

    Screening, Baseline, 7-14 days after implant placement, 6 weeks after implant placement, 4 months after implant placement, 6 months after implant placement and 12 months after implant placement

Study Arms (1)

BLT Implant Ø 2.9 mm

EXPERIMENTAL

The Straumann BLT Implants Ø 2.9 mm are available with a length of 10, 12 and 14 mm.

Device: BLT Implant Ø 2.9 mm

Interventions

Placement of Straumann BLT implants Ø 2.9 mm in central and lateral incisors in the mandible and lateral incisors in the maxilla for single tooth replacement followed by prosthetic loading.

Also known as: Short Diameter Implant (SDI)
BLT Implant Ø 2.9 mm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have voluntarily signed the Informed Consent Form before any study related procedures are performed, are willing and able to attend scheduled follow-up visits and agree that the pseudonymized data are collected and analyzed.
  • Patients must be males or females who are a minimum of 18 years of age.
  • Patients with a minimum of 4 weeks history of edentulism in the study area, minimal interdental space and in need of a single tooth replacement with a dental implant central and lateral incisors in the mandible and lateral incisors in the maxilla (Federation Dentaire Internationale (FDI) positions 12, 22, 31, 32, 41 or 42).
  • Presence of natural tooth or implants adjacent to the study implant position (single tooth gap).
  • Patients with complete soft tissue coverage of the socket at implant placement.

You may not qualify if:

  • Patients with inadequate bone volume and / or quality or metabolic bone disorder.
  • Patients with local root remnants.
  • Patients with inadequate wound healing capacity.
  • Patients with not completed maxillary and mandibular growth.
  • Patients with serious internal medical problems, uncontrolled bleeding disorders, psychoses, prolonged therapy-resistant functional disorders, xerostomia, weakened immune system, illnesses requiring periodic use of steroids or uncontrollable endocrine disorders.
  • Patients with poor general state of health.
  • Patients with drug or alcohol abuse.
  • Patients with allergies or hypersensitivity to chemical ingredients of titanium-zirconium alloy.
  • Patients with conditions or circumstances, in the opinion of the Investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability.
  • A woman who is pregnant or planning to become pregnant at any point during the study duration.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Kieferchirurgische Gemeinschaftspraxis Dr. Dr. Stroink & Kollegen

Düsseldorf, 40210, Germany

Location

Medi+

Mainz, 55128, Germany

Location

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Mund-Kiefer-Gesichtschirurgie, Plastische Operationen

Mainz, 55131, Germany

Location

Universitätsklinikum Münster, Klinik für Mund-, Kiefer- und Gesichtschirurgie

Münster, 48149, Germany

Location

Kieferchirurgische Praxen Hentschel & Herrmann

Zwickau, 08056, Germany

Location

Related Publications (14)

  • Steinemann SG. Titanium--the material of choice? Periodontol 2000. 1998 Jun;17:7-21. doi: 10.1111/j.1600-0757.1998.tb00119.x. No abstract available.

    PMID: 10337309BACKGROUND
  • Gottlow J, Dard M, Kjellson F, Obrecht M, Sennerby L. Evaluation of a new titanium-zirconium dental implant: a biomechanical and histological comparative study in the mini pig. Clin Implant Dent Relat Res. 2012 Aug;14(4):538-45. doi: 10.1111/j.1708-8208.2010.00289.x. Epub 2010 Jun 25.

    PMID: 20586785BACKGROUND
  • Kobayashi E, Matsumoto S, Doi H, Yoneyama T, Hamanaka H. Mechanical properties of the binary titanium-zirconium alloys and their potential for biomedical materials. J Biomed Mater Res. 1995 Aug;29(8):943-50. doi: 10.1002/jbm.820290805.

    PMID: 7593037BACKGROUND
  • Al-Nawas B, Bragger U, Meijer HJ, Naert I, Persson R, Perucchi A, Quirynen M, Raghoebar GM, Reichert TE, Romeo E, Santing HJ, Schimmel M, Storelli S, ten Bruggenkate C, Vandekerckhove B, Wagner W, Wismeijer D, Muller F. A double-blind randomized controlled trial (RCT) of Titanium-13Zirconium versus Titanium Grade IV small-diameter bone level implants in edentulous mandibles--results from a 1-year observation period. Clin Implant Dent Relat Res. 2012 Dec;14(6):896-904. doi: 10.1111/j.1708-8208.2010.00324.x. Epub 2011 Mar 17.

    PMID: 21414131BACKGROUND
  • Benic GI, Gallucci GO, Mokti M, Hammerle CH, Weber HP, Jung RE. Titanium-zirconium narrow-diameter versus titanium regular-diameter implants for anterior and premolar single crowns: 1-year results of a randomized controlled clinical study. J Clin Periodontol. 2013 Nov;40(11):1052-61. doi: 10.1111/jcpe.12156. Epub 2013 Sep 8.

    PMID: 24015975BACKGROUND
  • Al-Nawas B, Domagala P, Fragola G, Freiberger P, Ortiz-Vigon A, Rousseau P, Tondela J. A Prospective Noninterventional Study to Evaluate Survival and Success of Reduced Diameter Implants Made From Titanium-Zirconium Alloy. J Oral Implantol. 2015 Aug;41(4):e118-25. doi: 10.1563/AAID-JOI-D-13-00149. Epub 2014 Mar 25.

    PMID: 24666383BACKGROUND
  • Quirynen M, Al-Nawas B, Meijer HJ, Razavi A, Reichert TE, Schimmel M, Storelli S, Romeo E; Roxolid Study Group. Small-diameter titanium Grade IV and titanium-zirconium implants in edentulous mandibles: three-year results from a double-blind, randomized controlled trial. Clin Oral Implants Res. 2015 Jul;26(7):831-40. doi: 10.1111/clr.12367. Epub 2014 Apr 9.

    PMID: 24713048BACKGROUND
  • Klein MO, Schiegnitz E, Al-Nawas B. Systematic review on success of narrow-diameter dental implants. Int J Oral Maxillofac Implants. 2014;29 Suppl:43-54. doi: 10.11607/jomi.2014suppl.g1.3.

    PMID: 24660189BACKGROUND
  • Hammerle CH, Chen ST, Wilson TG Jr. Consensus statements and recommended clinical procedures regarding the placement of implants in extraction sockets. Int J Oral Maxillofac Implants. 2004;19 Suppl:26-8. No abstract available.

    PMID: 15635943BACKGROUND
  • Mombelli A, van Oosten MA, Schurch E Jr, Land NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol. 1987 Dec;2(4):145-51. doi: 10.1111/j.1399-302x.1987.tb00298.x. No abstract available.

    PMID: 3507627BACKGROUND
  • Buser D, Martin W, Belser UC. Optimizing esthetics for implant restorations in the anterior maxilla: anatomic and surgical considerations. Int J Oral Maxillofac Implants. 2004;19 Suppl:43-61.

    PMID: 15635945BACKGROUND
  • Furhauser R, Florescu D, Benesch T, Haas R, Mailath G, Watzek G. Evaluation of soft tissue around single-tooth implant crowns: the pink esthetic score. Clin Oral Implants Res. 2005 Dec;16(6):639-44. doi: 10.1111/j.1600-0501.2005.01193.x.

    PMID: 16307569BACKGROUND
  • Laurell L, Lundgren D. Marginal bone level changes at dental implants after 5 years in function: a meta-analysis. Clin Implant Dent Relat Res. 2011 Mar;13(1):19-28. doi: 10.1111/j.1708-8208.2009.00182.x.

    PMID: 19681932BACKGROUND
  • Walter C, Sagheb K, Blatt S, Klein MO, Herrmann J, Kleinheinz J, Al-Nawas B. Evaluation of the clinical safety and performance of a narrow diameter (2.9 mm) bone-level implant: a 1-year prospective single-arm multicenter study. Int J Implant Dent. 2023 Sep 19;9(1):32. doi: 10.1186/s40729-023-00495-x.

MeSH Terms

Conditions

Tooth Loss

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesTooth Diseases

Results Point of Contact

Title
Dr. Michael McCaskey, Team Leader Clinical Research
Organization
Institut Straumann AG

Study Officials

  • Keyvan Sagheb, Dr.

    Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Mund-Kiefer-Gesichtschirurgie, Plastische Operationen

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2016

First Posted

March 4, 2016

Study Start

February 1, 2016

Primary Completion

June 30, 2019

Study Completion

November 30, 2019

Last Updated

August 31, 2021

Results First Posted

September 17, 2020

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations